August 2012 Vol 5, No 5, Special Issue ASCO 2012 Payers' Perspective

Renal-Cell Carcinoma

First-Line Treatments for Metastatic Renal-Cell Carcinoma Are Evolving

Renal-Cell Carcinoma

Tivozanib Outperforms Sorafenib as First-Line Treatment in Advanced Renal-Cell Carcinoma

Prostate Cancer

In Head-to-Head Comparison, Continuous Beats Intermittent Hormonal Therapy for Metastatic Prostate Cancer

Chemotherapy-Related Toxicity Adds to Economic Burden in Metastatic Breast Cancer

Caroline Helwick

Prostate Cancer

A Promising New Gene Test to Differentiate Between Aggressive and Indolent Disease

Multiple Myeloma

Pomalidomide Shows Strong Activity in Relapsed/Refractory Myeloma

Caroline Helwick

Prostate Cancer

Agent that Targets Heat Shock Protein Shows Activity in Castration-Resistant Prostate Cancer

Multiple Myeloma

First Oral Proteasome Inhibitor Active in Myeloma

Prostate Cancer

Abiraterone Before Chemotherapy a Successful Strategy in Prostate Cancer

Molecular Profiling Guiding Cancer Therapy

Caroline Helwick

1
2
3
4

Page 1 of 4
Results 1 - 10 of 33

SUBSCRIBE

© Amplity Health. All rights reserved.

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

AHDB Print Edition

AHDB Weekly e‑Newsletter

I have reviewed and consent to the terms of AHDB's Privacy Policy, and AHDB has my permission to retain my information in its database, and to forward pertinent communications to me.